Clinical trial
Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome
NCT04093531 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome
- Lead sponsor
- University of Rochester
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 15, 2020
- Completion date
- May 11, 2022
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary sjögren syndrome